UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model

Scientific reports, 2019-02, Vol.9 (1), p.1580-1580, Article 1580

2019

Volltextzugriff (PDF)

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy

EMBO molecular medicine, 2018-02, Vol.10 (2), p.239-253

2018

Volltextzugriff (PDF)

Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations

Molecular therapy. Nucleic acids, 2022-09, Vol.29, p.733-748

2022

Volltextzugriff (PDF)

A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice

Human molecular genetics, 2010-12, Vol.19 (24), p.4820-4836

2010

Volltextzugriff (PDF)

Therapy for dominant inherited diseases by allele-specific RNA interference: successes and pitfalls

Current gene therapy, 2015-01, Vol.15 (5), p.503-510

2015

Volltextzugriff (PDF)

Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy

Molecular therapy. Nucleic acids, 2022-03, Vol.27, p.1179-1190

2022

Volltextzugriff (PDF)

Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy

Molecular therapy. Nucleic acids, 2018-03, Vol.10, p.376-386

2018

Volltextzugriff (PDF)

A Centronuclear Myopathy – Dynamin 2 Mutation Impairs Autophagy in Mice

Traffic (Copenhagen, Denmark), 2012-06, Vol.13 (6), p.869-879

2012

Volltextzugriff (PDF)

Skeletal Muscle Biopsy Analysis in Reducing Body Myopathy and Other FHL1-Related Disorders

Journal of neuropathology and experimental neurology, 2013-09, Vol.72 (9), p.833-845

2013

Volltextzugriff (PDF)

Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicing

Molecular therapy. Nucleic acids, 2016-09, Vol.5 (9), p.e362-e362, Article e362

2016

Volltextzugriff (PDF)

Dynamin 2 and human diseases

Journal of molecular medicine (Berlin, Germany), 2010-04, Vol.88 (4), p.339-350

2010

Volltextzugriff (PDF)

Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset

Annals of neurology, 2007-12, Vol.62 (6), p.666-670

2007

Volltextzugriff (PDF)

Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis

Human mutation, 2009-10, Vol.30 (10), p.1419-1427

2009

Volltextzugriff (PDF)

A new centronuclear myopathy phenotype due to a novel dynamin 2 mutation

Neurology, 2009-01, Vol.72 (1), p.93-95

2009

Volltextzugriff (PDF)

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy

Circulation. Arrhythmia and electrophysiology, 2017-12, Vol.10 (12), p.428-431

2017

Volltextzugriff (PDF)

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy

EMBO molecular medicine, 2017-12, Vol.10, p.239-253

2017

Volltextzugriff (PDF)

Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice

Cardiovascular research, 2004-08, Vol.63 (2), p.293-304

2004

Volltextzugriff (PDF)

A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: Clinical and pathological findings

Neuromuscular disorders : NMD, 2008-04, Vol.18 (4), p.334-338

2008

Volltextzugriff (PDF)

Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster

Basic research in cardiology, 2005-03, Vol.100 (2), p.161-170

2005

Volltextzugriff (PDF)

Targeted inactivation of the murine cardiac myosin-binding protein C gene leads to hypertrophic cardiomyopathy

Journal of molecular and cellular cardiology, 2002-06, Vol.34 (6), p.A15-A15

2002

Volltextzugriff (PDF)

Intermédiation financière française et intermédiation financière ouest-allemande : perspectives pour une réforme

Revue d'économie industrielle, 1984, Vol.30 (1), p.77-88

Prudhon, Bernard

1984

Volltextzugriff (PDF)

Intermédiation financière française et intermédiation financière ouest-allemande: perspectives pour une réforme

Revue d'économie industrielle, 1984, Vol.30 (1), p.77-88

Prudhon, Bernard

1984

Volltextzugriff (PDF)

(Re)constructions/(Re)inventions/(Re)mediations in 20th Century English Literature

Études britanniques contemporaines, 2018-06

2018

Volltextzugriff (PDF)

Another man-made crisis in Rwanda: international community at fault

The Lancet (British edition), 1995-04, Vol.345 (8954), p.918-918

1995

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Sprache

Englisch
(23)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(16)
Life Sciences
(15)
Humans
(11)
Animals
(8)
Human Health And Pathology
(8)
Mutation
(8)
Dynamin Ii - Genetics
(7)
Dynamin 2
(6)
Medicine, Research & Experimental
(6)
Research & Experimental Medicine
(6)
Biological And Medical Sciences
(5)
Endocytosis
(5)
Gene Therapy
(5)
Muscle, Skeletal - Pathology
(5)
Mutation - Genetics
(5)
Myopathies, Structural, Congenital - Genetics
(5)
Neurology
(5)
Genetics & Heredity
(4)
Medical Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy

Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations

A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice

Therapy for dominant inherited diseases by allele-specific RNA interference: successes and pitfalls

Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy

Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy

A Centronuclear Myopathy – Dynamin 2 Mutation Impairs Autophagy in Mice

Skeletal Muscle Biopsy Analysis in Reducing Body Myopathy and Other FHL1-Related Disorders

Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicing

Dynamin 2 and human diseases

Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset

Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis

A new centronuclear myopathy phenotype due to a novel dynamin 2 mutation

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy

Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice

A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: Clinical and pathological findings

Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster

Targeted inactivation of the murine cardiac myosin-binding protein C gene leads to hypertrophic cardiomyopathy

Intermédiation financière française et intermédiation financière ouest-allemande : perspectives pour une réforme

Intermédiation financière française et intermédiation financière ouest-allemande: perspectives pour une réforme

(Re)constructions/(Re)inventions/(Re)mediations in 20th Century English Literature

Another man-made crisis in Rwanda: international community at fault

Suchergebnisse filtern